General Counsel & Head of Compliance
Laetitia Szaller
Laetitia Szaller has over 20 years of experience, including 18 in pharmaceuticals and medical devices, leading complex multi-jurisdictional legal matters, M&A, and partnerships.
At Egetis, she heads global legal, compliance, ERM, and ESG, supporting EU and US launch readiness since December 2023. Previously at AM-Pharma, she drove legal operations and corporate development, including IPO readiness and a key Japanese out-licensing deal. At UCB, she served as Associate GC for BD, M&A, and Antitrust, leading major global transactions and earning Top Talent recognition. She also held senior roles at Zoetis (Pfizer), Abbott Vascular, and contributed to EU policymaking via EFPIA. Earlier, she led major global negotiations and restructuring projects at Carlson Rezidor and Wabco.
Laetitia holds qualifications as a lawyer in both the UK and Belgium, showcasing her extensive international experience. Renowned for her insights, she is a regular speaker at various legal conferences, contributing her wealth of knowledge and expertise to the legal community.
Number of shares in Egetis: 48,460 shares and 952,700 employee stock options.